PLEK2: a potential biomarker for metastasis and prognostic evaluation in uveal melanoma
BackgroundUveal melanoma (UVM) is an aggressive tumor known for its high metastatic rate, making it necessary to delineate potential molecules that may promote the development of UVM. PLEK2 has been found to promote the progression and metastasis of some tumors, but its role in UVM has not yet been...
Saved in:
| Main Authors: | Yichong Liu, Haiyue Wang, Qian Zhang, Xiaodi Gao, Yiqing Ji, Yuanzhang Zhu, Jingjing Zhang, Wenjuan Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1507576/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
by: S. V. Saakyan, et al.
Published: (2021-12-01) -
The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target
by: Yunpeng Zou, et al.
Published: (2025-08-01) -
Global incidence and prevalence in uveal melanoma
by: Xincen Hou, et al.
Published: (2024-11-01) -
Current Therapies and Potential Strategies for Uveal Melanoma
by: Sarah Scoles, et al.
Published: (2025-04-01) -
Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
by: V. A. Yarovaya, et al.
Published: (2023-10-01)